New Updates to the Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline <p><span>The recurrence and progression probability rates depend on several clinical and pathologic factors. Therefore, the ability to predict risk of recurrence and progression and treating non-muscle invasive bladder cancer (NMIBC) appropriately is important. This Guideline provides a risk-stratified clinical framework for the management of NMIBC.</span></p> <p><em><strong>Note:&nbsp;Access to the full Guideline now requires a login.</strong> If you do not have an AUA Account, you can create a free one.</em></p> Learn More h3